Baton Rouge, LANCT05958368Now EnrollingIRB Ready

Diabetes Mellitus, Type 2 Clinical Trial in Baton Rouge, LA

Access cutting-edge diabetes mellitus, type 2 treatment through this clinical trial at a research site in Baton Rouge. Study-provided care at no cost to qualified participants.

Sponsored by Pennington Biomedical Research Center

Quick Self-Assessment

See if you qualify for this Baton Rouge location

Preparing your pre-screening questions…

Expert Care in Baton Rouge

Access diabetes mellitus, type 2 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetes mellitus, type 2 treatment provided free

Apply for This Baton Rouge Location

Check if you qualify for this diabetes mellitus, type 2 clinical trial in Baton Rouge, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baton Rouge

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baton Rouge site if eligible
  4. 4Begin participation

About This Diabetes Mellitus, Type 2 Study in Baton Rouge

The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.

Sponsor: Pennington Biomedical Research Center

Who Can Participate

Inclusion Criteria

Participant reported diagnosis of Type 2 diabetes
HbA1c between 5.7%-11% (inclusive) and / or fasting blood glucose of ≥ 100 mg/dL
BMI 27-50 kg/m2 (inclusive)
Age range - 18 - 65 years (inclusive)
On stable regimen of all medications (including diabetes) for at least 3 months (brief regimens of medications such as antibiotics, steroids, etc. are permitted)
Willing to follow all requirements of study protocol including blood draws
Under the care of a physician who will be responsible for managing the subject's diabetes
Willing to give release to provide their treating MD with information about the trial

Exclusion Criteria

Not willing or unable to consume study foods including avocados
Participation in a weight control program within the past 3 months or weight loss of ≥ 5 kg in the previous 3 months
Taking prescription or OTC weight loss medications within last 4 weeks
History of a surgical procedure for weight loss in last 5 years (e.g. gastroplasty, gastric by-pass, gastrectomy or partial gastrectomy, adjustable banding, gastric sleeve)
History of major surgery within three months of enrollment
Type 1 diabetes, insulin dependent type 2 diabetes, thiazolidinediones (including rosiglitazone and pioglitazone)
Renal insufficiency consisting of potassium over 5.5 (mmol/L) on a non-hemolyzed specimen, or a creatinine over 2.5 mg/dL
Bilirubin over 3 (mg/dL) or an albumin less than 3 (g/dL)
ALT \> 3 (IU/L) times the upper limit of normal (normal range is 7-56)
Evidence of more than 1 severe hypoglycemic event (episode requiring emergency medical services) in the past 12 months, unless the participant's treating physician provides written clearance for participation.
Those on higher doses of diuretics (furosemide 40mg or higher or comparable)
Unstable heart disease (an ongoing workup or treatment for a cardiac symptom such as unstable angina, coronary ischemia)
Presence of implanted cardiac defibrillator
Blood pressure ≥180/100 mm Hg. If a potential participant has a BP above the inclusion criteria it is acceptable to re-test this potential participant within one week of the original test.
Thyroid disease for which the participant is untreated or has had treatment changed within the last 6 months. History of thyroid disease or current thyroid disease treated with a stable medication regimen for at least 6 months is acceptable
Uncontrolled gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer disease, Crohn's disease, chronic diarrhea, or active gallbladder disease
Current cancer or cancer treatment, or a history of cancer or cancer treatment within the last 3 years. Persons with successfully resected non-melanoma carcinoma of the skin may be enrolled.
Dementia, psychiatric illness, or substance abuse that may interfere with adherence (e.g., illness that is currently unstable or resistant to first-line therapy; substance abuse in the past year)
Women who are pregnant, lactating, trying to become pregnant or unwilling to use an effective means of birth control
Currently consuming \>14 alcoholic drinks (1 drink = 12 fl oz beer, 4 fl oz wine or 1.5 fl oz liquor) per week and unwilling to stop intake during study participation
Participation in another clinical trial within 30 days prior to enrollment
Any other condition or factor which in the opinion of the study physician or investigator makes it inadvisable for the candidate to participate in the trial

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baton Rouge?

Yes, this clinical trial (NCT05958368) has an active research site in Baton Rouge, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetes Mellitus, Type 2 Treatment Options in Baton Rouge, LA

If you're searching for diabetes mellitus, type 2 treatment options in Baton Rouge, LA, this clinical trial (NCT05958368) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baton Rouge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetes mellitus, type 2 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetes mellitus, type 2 clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Baton Rouge, LA

See all pulmonary embolism clinical trials recruiting in Baton Rouge — not just this study.

Browse Pulmonary Embolism Trials in Baton Rouge →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Baton Rouge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baton Rouge, LA